nach oben

AIDS and Behavior

Erschienen in:

01.08.2010 | Original Paper

Preferences for Characteristics of Antiretroviral Therapy Provision in Johannesburg, South Africa: Results of a Conjoint Analysis

verfasst von: Marjorie Opuni, David Bishai, Glenda E. Gray, James A. McIntyre, Neil A. Martinson

Erschienen in: AIDS and Behavior | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

A survey was administered to HIV-infected patients and a sample in Soweto and the Johannesburg inner city to measure preferences for antiretroviral therapy (ART) provision. The 25 to 49-year-old male and female respondents viewed 20 sets of three hypothetical ART clinic choices after reading information on ART. Each set had a permutation of four levels of: monthly ART price, clinic waiting times, HIV clinic branding and clinic staff attitudes. For each set, respondents selected the preferred mix of characteristics and indicated if they would pay for it. For every ZAR 100 (USD PPP 25) increase in price, the average probability of selecting a clinic decreased by 2.8 and 3.0% in the HIV patient and household samples, respectively. Cost as well as staff attitude, wait time, and clinic branding may constitute important barriers to ART uptake and adherence in resource-poor settings.

Beusterien KM, Dziekan K, Schrader S, Flood E, Flood R, Shearer A, et al. Patient preferences among third agent HIV medications: a US and German perspective. AIDS Care. 2007;19(8):982–8. doi:10.1080/09540120701294278.CrossRefPubMed

Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367(9513):817–24. doi:10.1016/S0140-6736(06)68337-2.CrossRefPubMed

Department of Health South Africa. National HIV and syphilis prevalence survey 2006. Pretoria: Department of Health; 2006.

Department of Health South Africa. HIV and AIDS and STI strategic plan for South Africa, 2007–2011. Pretoria: Department of Health; 2007.

Dreschsler D, Jutting J. Private health insurance in developing countries?. Paris: OECD; 2005.

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006;367(9519):1335–42. doi:10.1016/S0140-6736(06)68580-2.CrossRefPubMed

Goldstein H. Multilevel statistical models. 3rd ed. London, England: Arnold; 2003.

Hanson K, McPake B, Nakamba P, Archard L. Preferences for hospital quality in Zambia: results from a discrete choice experiment. Health Econ. 2005;14(7):687–701. doi:10.1002/hec.959.CrossRefPubMed

Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65. doi:10.1080/09540120701244943.CrossRefPubMed

10.

Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet. 2006;367(9525):1870–2. doi:10.1016/S0140-6736(06)68809-0.CrossRefPubMed

11.

Harries AD, Schouten EJ, Makombe SD, Libamba E, Neufville HN, Some E, et al. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ. 2007;85(2):152–5. doi:10.2471/BLT.06.032060.CrossRefPubMed

12.

Katabira ET, Oelrichs RB. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges. AIDS (London, England). 2007;21(Suppl 4):S5–10. doi:10.1097/01.aids.0000279701.93932.ef.

14.

Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS (London, England). 2005;19(18):2141–8.

13.

Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R. Determinants of mortality and non-death losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis. 2006;43(6):770–6. doi:10.1086/507095.CrossRefPubMed

15.

Libamba E, Makombe S, Harries AD, Chimzizi R, Salaniponi FM, Schouten EJ, et al. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes—the case of Malawi. Int J Tuberc Lung Dis. 2005;9(10):1062–71.PubMed

16.

Libamba E, Makombe S, Mhango E, de Ascurra Teck O, Limbambala E, Schouten EJ, et al. Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ. 2006;84(4):320–6.PubMed

17.

Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, et al. Malawi’s contribution to “3 by 5”: achievements and challenges. Bull World Health Organ. 2007;85(2):156–60. doi:10.2471/BLT.05.033688.CrossRefPubMed

18.

Louviere J, Henley D, Woodworth G, Meyer R, Levin I, Sonter J, et al. Laboratory simulation verses revealed preference methods for estimating travel demand models: an empirical comparison. Transp Res Rec. 1981;79:42–51.

19.

Louviere J, Hensher D, Swait J. Stated choice methods: analysis and applications. Cambridge: Cambridge University Press; 2000.CrossRef

20.

Lowrance D, Filler S, Makombe S, Harries A, Aberle-Grasse J, Hochgesang M, et al. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Tropical Med Int Health. 2007;12(3):377–81.CrossRef

21.

Makombe S, Libamba E, Mhango E, de Ascurra Teck O, Aberle-Grasse J, Hochgesang M, et al. Who is accessing antiretroviral therapy during national scale-up in Malawi? Trans R Soc Trop Med Hyg. 2006;100(10):975–9. doi:10.1016/j.trstmh.2005.11.007.CrossRefPubMed

22.

Miguel FS, Ryan M, Amaya-Amaya M. ‘Irrational’ stated preferences: a quantitative and qualitative investigation. Health Econ. 2005;14(3):307–22. doi:10.1002/hec.912.CrossRefPubMed

23.

Miles K, Clutterbuck DJ, Seitio O, Sebego M, Riley A. Antiretroviral treatment roll-out in a resource-constrained setting: capitalizing on nursing resources in Botswana. Bull World Health Organ. 2007;85(7):555–60. doi:10.2471/BLT.06.033076.CrossRefPubMed

24.

Mitchell RC, Carson RT. Using surveys to value public goods: the contingent valuation method. Washington, DC: Resources for the Future; 1989.

25.

Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006;20(9):649–57. doi:10.1089/apc.2006.20.649.CrossRefPubMed

26.

Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S123–6. doi:10.1097/01.qai.0000248348.25630.74.PubMed

27.

Muko KN, Ngwa VC, Chigang LC, Ngwa IG, Meiburg A, Shu EN. Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: a rural case study in Cameroon. J Soc Asp HIV/AIDS Res Alliance. 2004;1(2):107–13.

28.

Nattrass N. South Africa’s “rollout” of highly active antiretroviral therapy—a critical assessment. J Acquir Immune Defic Syndr. 2006;43(5):618–23.PubMed

29.

Newman PA, Duan N, Lee SJ, Rudy ET, Seiden DS, Kakinami L, et al. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Vaccine. 2006;24(12):2094–101. doi:10.1016/j.vaccine.2005.11.013.CrossRefPubMed

30.

Orme B. Getting started with conjoint analysis. Madison, WI: Research Publishers LLC; 2006.

31.

Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res. 2002;37(6):1681–705. doi:10.1111/1475-6773.01115.CrossRefPubMed

32.

Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modleing using Stata. College Station, Texas: StataCorp LP; 2005.

33.

Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S Afr Med J. 2007;97(7):524–9.PubMed

34.

Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med. 1999;48(4):535–46. doi:10.1016/S0277-9536(98)00374-8.CrossRefPubMed

35.

Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ (Clin Res Ed). 2000;320(7248):1530–3. doi:10.1136/bmj.320.7248.1530.CrossRef

36.

Ryan M, McIntosh E, Shackley P. Methodological issues in the application of conjoint analysis in health care. Health Econ. 1998;7(4):373–8. doi:10.1002/(SICI)1099-1050(199806)7:4<373::AID-HEC348>3.0.CO;2-J.CrossRefPubMed

37.

Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001;5(5):1–186.PubMed

38.

Schneider H, Blaauw D, Gilson L, Chabikuli N, Goudge J. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Reprod Health Matters. 2006;14(27):12–23. doi:10.1016/S0968-8080(06)27232-X.CrossRefPubMed

39.

Sow PS, Otieno LF, Bissagnene E, Kityo C, Bennink R, Clevenbergh P, et al. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries. J Acquir Immune Defic Syndr. 2007;44(3):262–7. doi:10.1097/QAI.0b013e31802bf109.CrossRefPubMed

40.

WHO, UNAIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report, April 2007. Geneva: WHO, UNAIDS, UNICEF; 2007.

Titel: Preferences for Characteristics of Antiretroviral Therapy Provision in Johannesburg, South Africa: Results of a Conjoint Analysis
verfasst von: Marjorie Opuni
David Bishai
Glenda E. Gray
James A. McIntyre
Neil A. Martinson
Publikationsdatum: 01.08.2010
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2010
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-009-9584-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Neighborhood-Level Correlates of Consistent Condom Use among Men Who have Sex with Men: A Multi-Level Analysis

Two-Year Follow-Up of Sexual Behavior Among HIV-Uninfected Household Members of Adults Taking Antiretroviral Therapy in Uganda: No Evidence of Disinhibition

Correlates of HIV/STD Testing and Willingness to Test among Rural-to-Urban Migrants in China

Affective Correlates of Stimulant Use and Adherence to Anti-retroviral Therapy Among HIV-positive Methamphetamine Users

Smoking Among HIV Positive New Yorkers: Prevalence, Frequency, and Opportunities for Cessation